Johan Bulten
Overview
Explore the profile of Johan Bulten including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
152
Citations
1882
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meijs-Hermanns P, Werner H, Kooreman L, Bretova P, Weinberger V, Vrede S, et al.
Int J Gynecol Cancer
. 2025 Feb;
:101682.
PMID: 40011117
Objective: This study aimed to evaluate the association between pre-operative progesterone receptor (PR) and p53 expression and prognosis in pre-operative grade 2 endometrioid endometrial carcinoma compared with grade 1 and...
2.
Van Bommel M, Steenbeek M, IntHout J, Van Garderen T, Harmsen M, Arts-De Jong M, et al.
BJOG
. 2025 Jan;
PMID: 39823150
Objective: To compare menopause-related quality of life (QoL) after risk-reducing salpingectomy (RRS) versus risk-reducing salpingo-oophorectomy (RRSO) until 3 years of post-surgery. Design: A prospective study (TUBA study) with treatment allocation...
3.
Thuijs N, Voss F, Ewing-Graham P, Dasgupta S, Berkhof J, Bulten J, et al.
Cancers (Basel)
. 2024 Dec;
16(23).
PMID: 39682153
Background: Recently, the immunohistochemical markers cytokeratin 17 (CK17) and SRY-box2 (SOX2) have been evaluated as adjuncts for the diagnosis of high-grade vulvar intraepithelial neoplasia (VIN). In the present study, the...
4.
Vrede S, Van Weelden W, Bulten J, Gilks C, Teerenstra S, Huvila J, et al.
Gynecol Oncol
. 2024 Nov;
192():15-23.
PMID: 39515079
Objective: The prognostic relevance of hormonal biomarkers in endometrial cancer (EC) has been well-established. A refined three-tiered risk model for estrogen receptor (ER)/progesterone receptor (PR) expression was shown to improve...
5.
Luijten M, Van Weelden W, Lalisang R, Bulten J, Lindemann K, van Beekhuizen H, et al.
Cancers (Basel)
. 2024 Jun;
16(11).
PMID: 38893205
Background: Response to hormonal therapy in advanced and recurrent endometrial cancer (EC) can be predicted by oestrogen and progesterone receptor immunohistochemical (ER/PR-IHC) expression, with response rates of 60% in PR-IHC...
6.
Bleeker M, Bosse T, Van de Vijver K, Bart J, Horlings H, Jonges T, et al.
Int J Gynecol Pathol
. 2024 Feb;
43(5):457-463.
PMID: 38303108
Depth of invasion (DOI) is an important diagnostic parameter in patients with vulvar carcinoma, where a cutoff value of 1 mm largely determines the tumor stage and the need for...
7.
Vermorgen S, Gelton T, Bult P, Kusters-Vandevelde H, Hausnerova J, Van de Vijver K, et al.
Mod Pathol
. 2023 Dec;
37(2):100417.
PMID: 38154654
Endometrial biopsies are important in the diagnostic workup of women who present with abnormal uterine bleeding or hereditary risk of endometrial cancer. In general, approximately 10% of all endometrial biopsies...
8.
Lombaers M, Cornel K, Visser N, Bulten J, Kusters-Vandevelde H, Amant F, et al.
Cancers (Basel)
. 2023 May;
15(9).
PMID: 37174070
Patients with high-grade endometrial carcinoma (EC) have an increased risk of tumor spread and lymph node metastasis (LNM). Preoperative imaging and CA125 can be used in work-up. As data on...
9.
Reijnen C, Vrede S, Eijkelenboom A, Draak R, Sweegers S, Snijders M, et al.
Cancer Med
. 2023 Apr;
12(11):12365-12376.
PMID: 37081760
Background: Uterine clear cell carcinoma (CCC) consists of either pure clear cell histology but can also display other histological components (mixed uterine CCCs). In this study, the molecular and immunohistochemical...
10.
Hendrikse C, van der Ploeg P, van de Kruis N, Wilting J, Oosterkamp F, Theelen P, et al.
Cancer
. 2023 Mar;
129(9):1361-1371.
PMID: 36867576
Background: Advanced low-grade ovarian carcinoma (LGOC) is difficult to treat. In several studies, high estrogen receptor (ER) protein expression was observed in patients with LGOC, which suggests that antihormonal therapy...